BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 18773927)

  • 21. Effect of ventromedial hypothalamic lesions on the secretion of somatostatin, insulin, and glucagon by the perfused rat pancreas.
    Goto Y; Carpenter RG; Berelowitz M; Frohman LA
    Metabolism; 1980 Oct; 29(10):986-90. PubMed ID: 6106879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new benzothiadiazine derivative, LN 5330: effects on pancreatic hormones.
    Hillaire-Buys D; Ribes G; Blayac JP; Loubatières-Mariani MM
    Diabetologia; 1984 Dec; 27(6):583-6. PubMed ID: 6152237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ontogeny of ghrelin, obestatin, preproghrelin, and prohormone convertases in rat pancreas and stomach.
    Walia P; Asadi A; Kieffer TJ; Johnson JD; Chanoine JP
    Pediatr Res; 2009 Jan; 65(1):39-44. PubMed ID: 18784614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of obestatin- and ghrelin-producing cells in the gastrointestinal tract and pancreas of rats: an immunohistochemical and electron-microscopic study.
    Zhao CM; Furnes MW; Stenström B; Kulseng B; Chen D
    Cell Tissue Res; 2008 Mar; 331(3):575-87. PubMed ID: 18071756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Homologous pancreastatin inhibits insulin secretion without affecting glucagon and somatostatin release in the perfused rat pancreas.
    Peiró E; Dégano P; Miralles P; Silvestre RA; Marco J
    Regul Pept; 1991 Jul; 34(3):159-67. PubMed ID: 1681569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of (8-32) salmon calcitonin, an amylin antagonist, on insulin, glucagon and somatostatin release: study in the perfused pancreas of the rat.
    Silvestre RA; Salas M; Rodríguez-Gallardo J; García-Hermida O; Fontela T; Marco J
    Br J Pharmacol; 1996 Jan; 117(2):347-50. PubMed ID: 8789389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stimulatory effect of xenin-8 on insulin and glucagon secretion in the perfused rat pancreas.
    Silvestre RA; Rodríguez-Gallardo J; Egido EM; Hernández R; Marco J
    Regul Pept; 2003 Aug; 115(1):25-9. PubMed ID: 12873795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sulfonylurea compounds uncouple the glucose dependence of the insulinotropic effect of glucagon-like peptide 1.
    de Heer J; Holst JJ
    Diabetes; 2007 Feb; 56(2):438-43. PubMed ID: 17259389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of ghrelin on insulin and glucagon secretion: a study of isolated pancreatic islets and intact mice.
    Salehi A; Dornonville de la Cour C; Håkanson R; Lundquist I
    Regul Pept; 2004 May; 118(3):143-50. PubMed ID: 15003830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exendin-4 dose-dependently stimulates somatostatin and insulin secretion in perfused rat pancreas.
    Egido EM; Silvestre RA; Hernández R; Marco J
    Horm Metab Res; 2004 Sep; 36(9):595-600. PubMed ID: 15486809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential effects of glucagon-like peptide-1 (7-36)amide versus cholecystokinin on arginine-induced islet hormone release in vivo and in vitro.
    Guenifi A; Ahrén B; Abdel-Halim SM
    Pancreas; 2001 Jan; 22(1):58-64. PubMed ID: 11138972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, inhibits glucagon secretion via somatostatin (receptor subtype 2) in the perfused rat pancreas.
    de Heer J; Rasmussen C; Coy DH; Holst JJ
    Diabetologia; 2008 Dec; 51(12):2263-70. PubMed ID: 18795252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of bradykinin on secretion of insulin, glucagon, and somatostatin from the perfused rat pancreas.
    Yang C; Chao J; Hsu WH
    Metabolism; 1997 Oct; 46(10):1113-5. PubMed ID: 9322791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of glucagon and insulin secretion from the perfused rat pancreas by a B-cell-selective somatostatin analog.
    Weir GC; Schwarz JA; Mathe CJ
    Metabolism; 1980 Jan; 29(1):68-70. PubMed ID: 6986012
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dissociation of glucose stimulation of somatostatin and insulin release from glucose inhibition of glucagon release in the isolated perfused rat pancreas.
    Sorenson RL; Elde RP
    Diabetes; 1983 Jun; 32(6):561-7. PubMed ID: 6138289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in obestatin gene and GPR39 receptor expression in peripheral tissues of rat models of obesity, type 1 and type 2 diabetes.
    Kolodziejski PA; Pruszynska-Oszmalek E; Sassek M; Kaczmarek P; Szczepankiewicz D; Billert M; Mackowiak P; Strowski MZ; Nowak KW
    J Diabetes; 2017 Apr; 9(4):353-361. PubMed ID: 27106635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stimulation by 2-deoxy-D-glucose tetraacetates of hormonal secretion from the perfused rat pancreas.
    Leclercq-Meyer V; Kadiata MM; Malaisse WJ
    Am J Physiol; 1999 Apr; 276(4):E689-96. PubMed ID: 10198305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of spontaneous diabetes on hormone release in BB/Phi rats: comparison between the isolated perfused pancreas/stomach/duodenum/spleen and the isolated perfused pancreas.
    Boden G; Naji A; Barker CF; June V; Matschinsky FM
    Endocrinology; 1983 May; 112(5):1777-81. PubMed ID: 6131815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paracrine control of glucagon release by somatostatin (Review).
    Malaisse WJ
    Int J Mol Med; 2014 Mar; 33(3):491-8. PubMed ID: 24366344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tungstate stimulates insulin release and inhibits somatostatin output in the perfused rat pancreas.
    Silvestre RA; Egido EM; Hernández R; Marco J
    Eur J Pharmacol; 2005 Sep; 519(1-2):127-34. PubMed ID: 16126195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.